Moonlake Immunotherapeutics (MLTX)
$44.91
Moonlake Immunotherapeutics (MLTX) Share Price Forecast
Currently 22 wall-street analysts regularly analyze the financials of Moonlake Immunotherapeutics on a frequent basis to provide recommendations along with target share price. 22 analysts offering 12-month price forecasts for Moonlake Immunotherapeutics (MLTX) have a share price target of $73.13. This median of share price forecast represents a 62.84% upside from the latest price of $44.91 as on 26.07.24.
Moonlake Immunotherapeutics (MLTX) Price vs Consensus Price Target
Price
Target Price
As per the chart shown above, analysts believe that the Moonlake Immunotherapeutics (MLTX) share price will touch around $73.13 in next 12-months.
Moonlake Immunotherapeutics (MLTX) Share Price Forecast v/s Share Price Today
Below is a chart showing the percentage difference between Moonlake Immunotherapeutics's share price and its median forecast price. As on 26.07.24, the difference is -42.84%
Moonlake Immunotherapeutics (MLTX): Difference between Current Price & Median Forecasted Price
Difference in Percentage terms
Moonlake Immunotherapeutics (MLTX) Share Price : Analyst Recommendation
Based on 22 analysts tracking and researching Moonlake Immunotherapeutics (MLTX) share have buy recommendation on an average.
| 3M Ago | 1M Ago | Current | |
| Buy | 8 | 8 | 8 |
| Outperform | 9 | 10 | 10 |
| Hold | 3 | 3 | 4 |
| Underperform | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |
Moonlake Immunotherapeutics (MLTX) Share Price Technical Analysis
50 Day Moving Average v/s Current Share Price
Moving Average
Price
200 Day Moving Average v/s Current Share Price
Moving Average
Price
FAQs
The latest share price target for Moonlake Immunotherapeutics (MLTX) is $73.13, offered by 22 analysts offering 12-month price forecasts.
Moonlake Immunotherapeutics (MLTX) has a maximum of 0.63 upside potential, based on 22 analysts offering 12-month price forecasts.
Based on 22 analysts tracking and researching Moonlake Immunotherapeutics (MLTX), 81.82% have a buy recommendation. Remaining 18.18% have either sell or hold recommendations.
The latest share price of Moonlake Immunotherapeutics (MLTX) is $44.91 as of 26/07/2024.
18 of total 22 analysts offering stock ratings for Moonlake Immunotherapeutics MLTX have recommended buy rating.
₹0 US Stocks a/c Opening Fee